173 related articles for article (PubMed ID: 18543232)
1. [Analysis of HLA-Cw, KIR2D genetic variations in 2 Chinese populations].
Cai JH; Tian W; Li LX; Wang F; Sun KZ; Zeng QR; Guo SS; Cao Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):343-7. PubMed ID: 18543232
[TBL] [Abstract][Full Text] [Related]
2. [Frequency of HLA-Cw and Its Corresponding Killer Cell Immunoglobulin-like Receptors (KIR) among Blood Donors in Chinese Nanjing Han Ethnic Group].
Lin H; Ma L; Xue M; Liu YC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1469-73. PubMed ID: 26524059
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the expression of KIR and HLA-Cw in a Northeast Han population.
Han Y; Zhao L; Jiang Z; Ma N
Exp Ther Med; 2013 Jan; 5(1):300-304. PubMed ID: 23251287
[TBL] [Abstract][Full Text] [Related]
4. Allelic polymorphism of KIR2DL2/2DL3 in a southern Chinese population.
Zhen J; He L; Xu Y; Zhao J; Yu Q; Zou H; Sun G; Deng Z
Tissue Antigens; 2015 Nov; 86(5):362-7. PubMed ID: 26423800
[TBL] [Abstract][Full Text] [Related]
5. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires.
Crum KA; Logue SE; Curran MD; Middleton D
Tissue Antigens; 2000 Oct; 56(4):313-26. PubMed ID: 11098931
[TBL] [Abstract][Full Text] [Related]
6. Killer cell immunoglobulin-like receptor along with HLA-C ligand genes are associated with type 1 diabetes in Chinese Han population.
Zhi D; Sun C; Sedimbi SK; Luo F; Shen S; Sanjeevi CB
Diabetes Metab Res Rev; 2011 Nov; 27(8):872-7. PubMed ID: 22069276
[TBL] [Abstract][Full Text] [Related]
7. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
8. Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.
Shastry A; Sedimbi SK; Rajalingam R; Nikitina-Zake L; Rumba I; Wigzell H; Sanjeevi CB
Int J Immunogenet; 2008 Dec; 35(6):439-46. PubMed ID: 19046302
[TBL] [Abstract][Full Text] [Related]
9. Investigation of killer cell immunoglobulin-like receptors KIR2DL2 and KIR2DL3 diversity and identification of ten novel KIR2DL3 alleles in the Chinese Han population.
He Y; Tao S; Ying Y; He J; Zhu F; Lv H
Scand J Immunol; 2015 Apr; 81(4):265-71. PubMed ID: 25651940
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism analysis of killer cell immunoglobulin-like receptor genes in the Chinese Uygur population.
Wang HD; Zhu BF; Shen CM; Yuan GL; Yang G; Guo JN; Yan JW; Qin HX; Guo JX; Zhang LP; Jia XQ; Lucas R
Mol Biol Rep; 2012 Mar; 39(3):3017-28. PubMed ID: 21701829
[TBL] [Abstract][Full Text] [Related]
11. [Receptor-ligand analysis of killer cell Ig-like receptor in Jiangsu Han population].
Jiang LX; Xu LH; Qi CP; Wang YF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):863-5. PubMed ID: 22863597
[TBL] [Abstract][Full Text] [Related]
12. [Killer immunoglobulin-like receptor gene distribution in Guangdong Han population].
Yin XL; Guo KY; Ma HJ; Shang ZC; Xiao LL; Ye X; Zhao Y
Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1416-8. PubMed ID: 15604074
[TBL] [Abstract][Full Text] [Related]
13. [Association of molecular genetic polymorphism of KIR-HLA systems with acute leukemia in Southern Chinese Han].
Zhen J; Yang Z; Deng Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 May; 39(5):499-504. PubMed ID: 35598265
[TBL] [Abstract][Full Text] [Related]
14. [Distribution of KIR/HLA alleles among ethnic Han Chinese patients with hepatocellular carcinoma from southern China].
Gao S; Jiao B; Hong W; Cai C; Zhong Y; Quan Z; Chen H; Xu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 May; 36(5):439-442. PubMed ID: 31030428
[TBL] [Abstract][Full Text] [Related]
15. Killer immunoglobulin receptor genes and their HLA-C ligand are associated with Type 1 diabetes in an Eastern Indian population.
Sanjeevi S; Sun C; Kanungo A; Sanjeevi CB
Diabet Med; 2016 Jan; 33(1):91-6. PubMed ID: 26031759
[TBL] [Abstract][Full Text] [Related]
16. KIR genotyping in the selected population in Andhra Pradesh (India).
Vaishnav G; Krupanidhi S; Sanjeevi CB
Roum Arch Microbiol Immunol; 2014; 73(1-2):43-50. PubMed ID: 25518570
[TBL] [Abstract][Full Text] [Related]
17. [Killer Ig-like receptor gene content diversity and haplotype analysis in Chinese Han population in Shanghai].
Zhang L; Hsu KC; Liu XR; Yang JQ; Yao FJ; Xu LD; Dupont B; Fan LA
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):396-9. PubMed ID: 14556191
[TBL] [Abstract][Full Text] [Related]
18. The investigation of killer cell immunoglobulin-like receptor genotyping in patients with systemic lupus erytematosus and systemic sclerosis.
Tozkır JD; Tozkır H; Gürkan H; Dönmez S; Eker D; Pamuk GE; Pamuk ÖN
Clin Rheumatol; 2016 Apr; 35(4):919-25. PubMed ID: 26960450
[TBL] [Abstract][Full Text] [Related]
19. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
20. Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies.
David G; Morvan M; Gagne K; Kerdudou N; Willem C; Devys A; Bonneville M; Folléa G; Bignon JD; Retière C
Immunology; 2009 Oct; 128(2):172-84. PubMed ID: 19740374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
